Reviva Pharmaceuticals Holdings, Inc.
NASDAQ:RVPH
Balance Sheet
Balance Sheet Decomposition
Reviva Pharmaceuticals Holdings, Inc.
Reviva Pharmaceuticals Holdings, Inc.
Balance Sheet
Reviva Pharmaceuticals Holdings, Inc.
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
9
|
30
|
19
|
23
|
13
|
|
| Cash |
9
|
30
|
19
|
23
|
13
|
|
| Other Current Assets |
0
|
2
|
0
|
0
|
1
|
|
| Total Current Assets |
9
|
31
|
19
|
24
|
15
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
|
| Total Assets |
9
N/A
|
31
+258%
|
19
-40%
|
24
+25%
|
16
-35%
|
|
| Liabilities | ||||||
| Accounts Payable |
1
|
1
|
4
|
4
|
6
|
|
| Accrued Liabilities |
0
|
2
|
6
|
13
|
8
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
2
|
10
|
17
|
15
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
2
|
0
|
1
|
1
|
0
|
|
| Total Liabilities |
3
N/A
|
3
-18%
|
11
+287%
|
18
+71%
|
15
-18%
|
|
| Equity | ||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
58
|
67
|
95
|
134
|
164
|
|
| Additional Paid In Capital |
64
|
96
|
103
|
140
|
165
|
|
| Total Equity |
5
N/A
|
29
+425%
|
8
-71%
|
6
-32%
|
1
-86%
|
|
| Total Liabilities & Equity |
9
N/A
|
31
+258%
|
19
-40%
|
24
+25%
|
16
-35%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
9
|
14
|
20
|
28
|
47
|
|